|
HS2ST1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.944500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.349790E-02 |
| Normal-vs-Stage2 |
7.829200E-01 |
| Normal-vs-Stage3 |
1.739390E-01 |
| Normal-vs-Stage4 |
2.073400E-01 |
| Stage1-vs-Stage2 |
1.245830E-01 |
| Stage1-vs-Stage3 |
3.231600E-01 |
| Stage1-vs-Stage4 |
3.722600E-01 |
| Stage2-vs-Stage3 |
3.731200E-01 |
| Stage2-vs-Stage4 |
4.412000E-01 |
| Stage3-vs-Stage4 |
9.695200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.287500E-02 |
| Normal-vs-AfricanAmerican |
1.678630E-01 |
| Normal-vs-Asian |
3.844100E-02 |
| Caucasian-vs-AfricanAmerican |
9.508200E-01 |
| Caucasian-vs-Asian |
5.985200E-01 |
| AfricanAmerican-vs-Asian |
7.727600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.667200E-01 |
| Normal-vs-Female |
1.696380E-02 |
| Male-vs-Female |
1.819770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.964500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.351970E-01 |
| Normal-vs-Age(61-80Yrs) |
5.192800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.095200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.060020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.714500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.651600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.515800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.428000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.146000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.597400E-01 |
| Classical-VS-Follicular |
4.41610004120463E-09 |
| Classical-VS-Other |
4.451000E-01 |
| Classical-VS-Normal |
5.380300E-04 |
| Tall-VS-Follicular |
9.004100E-04 |
| Tall-VS-Other |
5.547800E-01 |
| Tall-VS-Normal |
4.716400E-02 |
| Follicular-VS-Other |
2.168600E-01 |
| Follicular-VS-Normal |
8.859900E-02 |
| Other-VS-Normal |
6.041200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.914000E-01 |
| Normal-vs-N1 |
3.385800E-01 |
| N0-vs-N1 |
7.040400E-01 |
|
|
